Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 22;15(1):252.
doi: 10.1186/s13244-024-01814-5.

Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium

Hans-Ulrich Kauczor  1 , Oyunbileg von Stackelberg  2 , Emily Nischwitz  2 , Joanna Chorostowska-Wynimko  3 , Monika Hierath  4 , Coline Mathonier  4 , Helmut Prosch  5 , Pamela Zolda  5 , Marie-Pierre Revel  6   7 , Ildikó Horváth  8   9 , Martina Koziar Vašáková  10 , Pippa Powell  11 , Miroslav Samarzija  12   13 , Torsten Gerriet Blum  14   15 ; and SOLACE Consortium
Affiliations

Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium

Hans-Ulrich Kauczor et al. Insights Imaging. .

Abstract

The Strengthening the Screening of Lung Cancer in Europe (SOLACE) initiative, supported by Europe's Beating Cancer Plan, is dedicated to advancing lung cancer screening. This initiative brings together the most extensive pan-European network of respiratory and radiology experts, involving 37 partners from 15 countries. SOLACE aims to enhance equitable access to lung cancer screening by developing targeted recruitment strategies for underrepresented and high-risk populations. Through comprehensive work packages, SOLACE integrates scientific research, pilot studies, and sustainability efforts to bolster regional and national screening efforts across EU member states. CRITICAL RELEVANCE STATEMENT: The SOLACE project aims to facilitate the optimization and implementation of equitable lung cancer screening programs across the heterogeneous healthcare landscape in EU member states. KEY POINTS: The effectiveness of lung cancer screening is supported by both scientific evidence and now increasing legislative support. SOLACE aims to develop, test, and disseminate tools to facilitate the realization of lung cancer screening at both a national and regional level. Previously underrepresented populations in lung cancer screening will be targeted by tailored recruitment strategies. SOLACE forms the first pan-European network of experts poised to drive real-world implementation of lung cancer screening.

Keywords: Early detection of cancer; Low-dose computed tomography; Lung; SOLACE.

PubMed Disclaimer

Conflict of interest statement

H.P. was speaker Honoria at AstraZeneca, BMS, Boehringer Ingelheim, Janssen, MSD, Novartis, Roche/Intermune, Sanofi, Siemens Healthcare, and Takeda. H.P. is an advisory board member of BMS, Boehringer Ingelheim, MSD, Roche/Intermune, and Sanofi. H.P. received travel grants from Boehringer Ingelheim, and he received research grants from Boehringer Ingelheim, AstraZeneca, Siemens, and Eu4Health. H.P. is a scientific advisor of Contexflow. H.P. is a member of the Insights into Imaging Scientific Editorial Board. He has not taken part in the review or selection process of this article. M.-P.R. is a beneficiary of AI solutions from GLEAMER, MEVIS, and DEEPHEALTH, and she received lecture fees from Bracco. H.-U.K. received research grants from Siemens, Philips, and Boehringer Ingelheim. H.-U.K. was a speaker of Honoraria at Siemens, Philips, Boehringer Ingelheim, and Sanofi, and is a scientific advisor to Median. M.H. and C.M. are employees of the ESR. They have not taken part in the review or selection process of this article.

Figures

Fig. 1
Fig. 1
Overview of SOLACE work packages
Fig. 2
Fig. 2
Overview of pilots. All SOLACE partners are indicated in blue. Dark and light blue represent the countries that do and do not have ongoing pilots and/or programs involved in SOLACE, respectively. Light gray countries are not involved in SOLACE
See this image and copyright information in PMC

References

    1. Malvezzi M, Carioli G, Bertuccio P et al (2017) European cancer mortality predictions for the year 2017, with focus on lung cancer. Ann Oncol. 10.1093/annonc/mdx033 - PubMed
    1. Malvezzi M, Santucci C, Boffetta P et al (2023) European cancer mortality predictions for the year 2023 with focus on lung cancer. Ann Oncol. 10.1016/j.annonc.2023.01.010 - PubMed
    1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 10.3322/caac.21660 - PubMed
    1. National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 10.1056/NEJMoa1102873 - PMC - PubMed
    1. National Lung Screening Trial Research Team (2013) Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 10.1056/NEJMoa1209120 - PMC - PubMed

LinkOut - more resources